litlas
ログインアカウント作成

David M. Berman

1977–2025 年に発表

101
論文数
24,704
被引用数
71
h 指数
92
i10 指数

被引用数

David M. Berman の年別被引用数1967 年: 被引用 1 件1979 年: 被引用 1 件1980 年: 被引用 1 件1985 年: 被引用 3 件1986 年: 被引用 2 件1991 年: 被引用 2 件1992 年: 被引用 18 件1993 年: 被引用 12 件1994 年: 被引用 17 件1995 年: 被引用 14 件1996 年: 被引用 18 件1997 年: 被引用 76 件1998 年: 被引用 114 件1999 年: 被引用 157 件2000 年: 被引用 137 件2001 年: 被引用 89 件2002 年: 被引用 72 件2003 年: 被引用 90 件2004 年: 被引用 148 件2005 年: 被引用 207 件2006 年: 被引用 260 件2007 年: 被引用 266 件2008 年: 被引用 266 件2009 年: 被引用 252 件2010 年: 被引用 300 件2011 年: 被引用 260 件2012 年: 被引用 263 件2013 年: 被引用 288 件2014 年: 被引用 277 件2015 年: 被引用 324 件2016 年: 被引用 344 件2017 年: 被引用 342 件2018 年: 被引用 290 件2019 年: 被引用 828 件2020 年: 被引用 801 件2021 年: 被引用 688 件2022 年: 被引用 470 件2023 年: 被引用 314 件2024 年: 被引用 476 件2025 年: 被引用 188 件2026 年: 被引用 12 件1968〜1978 年は被引用が無いため表示していません1981〜1984 年は被引用が無いため表示していません1987〜1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,751 件、この内訳の 33.8%中国: 引用元論文 965 件、この内訳の 8.7%イギリス: 引用元論文 639 件、この内訳の 5.8%ドイツ: 引用元論文 592 件、この内訳の 5.3%イタリア: 引用元論文 497 件、この内訳の 4.5%フランス: 引用元論文 430 件、この内訳の 3.9%カナダ: 引用元論文 416 件、この内訳の 3.7%日本: 引用元論文 323 件、この内訳の 2.9%スペイン: 引用元論文 322 件、この内訳の 2.9%オランダ: 引用元論文 292 件、この内訳の 2.6%オーストラリア: 引用元論文 288 件、この内訳の 2.6%スイス: 引用元論文 240 件、この内訳の 2.2%
0%33.8%その他 21.1%

機関

分野

  • Medicine50%
  • Biochemistry, Genetics and Molecular Biology35.8%
  • Immunology and Microbiology8.1%
  • Computer Science1.7%
  • Neuroscience1.2%
  • Engineering1%
  • その他2.2%

トピック

  • Cancer Immunotherapy and Biomarkers9.3%
  • Immunotherapy and Immune Responses6%
  • CAR-T cell therapy research4.6%
  • Epigenetics and DNA Methylation4.5%
  • Hedgehog Signaling Pathway Studies3.4%
  • Immune Cell Function and Interaction2.8%
  • その他69.4%

共著者

全論文

検索で開く
  1. Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

    著者: Dirk Schadendorf, F. Stephen Hodi, Caroline Robert, Jeffrey S. Weber, Kim Margolin, Omid Hamid, Debra A. Patt, Tai‐Tsang Chen, David M. Berman, Jedd D. Wolchok - Journal of Clinical Oncology 2015 被引用: 2,122

  2. Clinical implications of PTEN loss in prostate cancer

    著者: Tamara Jamaspishvili, David M. Berman, Ashley E. Ross, Howard I. Scher, Angelo M. De Marzo, Jeremy A. Squire, Tamara L. Lotan - Nature Reviews Urology 2018 被引用: 658

  3. Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

    著者: Mark E. Dudley, John R. Wunderlich, James Chih‐Hsin Yang, Richard M. Sherry, Suzanne L. Topalian, Nicholas P. Restifo, Richard E. Royal, Udai S. Kammula, D E White, Sharon Mavroukakis, Linda Rogers, Gerald Gracia, Stephanie A. Jones, David P. Mangiameli, Michelle M. Pelletier, Juan Gea‐Banacloche, Michael R. Robinson, David M. Berman, Armando Filie, Andrea Abati, Steven A. Rosenberg - Journal of Clinical Oncology 2005 被引用: 1,628

  4. The Proteogenomic Landscape of Curable Prostate Cancer

    著者: Ankit Sinha, Vincent Huang, Julie Livingstone, Jenny Wang, Natalie S. Fox, Natalie J. Kurganovs, Vladimir Ignatchenko, Katharina Fritsch, Nilgun Donmez, Lawrence E. Heisler, Yu-Jia Shiah, Cindy Q. Yao, Javier A. Alfaro, Stas Volik, Anna Lapuk, Michael Fraser, Ken J. Kron, Alex Murison, Mathieu Lupien, Cenk Sahinalp, Colin C. Collins, Bernard Têtu, Mehdi Masoomian, David M. Berman, Theodorus van der Kwast, Robert G. Bristow, Thomas Kislinger, Paul C. Boutros - Cancer Cell 2019 被引用: 278

  5. Evolving synergistic combinations of targeted immunotherapies to combat cancer

    著者: Ignacio Melero, David M. Berman, M. Ángela Aznar, Alan J. Korman, José Luis Perez‐Gracia, John B.A.G. Haanen - Nature reviews. Cancer 2015 被引用: 644

  6. A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing

    著者: Joyce E. Ohm, Kelly M. McGarvey, Xiaobing Yu, Linzhao Cheng, Kornel E. Schuebel, Leslie Cope, Helai P. Mohammad, Wei Chen, Vincent C. Daniel, Wayne Yu, David M. Berman, Thomas Jenuwein, Kevin Pruitt, Saul J. Sharkis, D. Neil Watkins, James G. Herman, Stephen B. Baylin - Nature Genetics 2007 被引用: 1,148

  7. An immune-active tumor microenvironment favors clinical response to ipilimumab

    著者: Rui‐Ru Ji, Scott D. Chasalow, Lisu Wang, Omid Hamid, Henrik Schmidt, John Cogswell, Suresh Alaparthy, David M. Berman, Maria Jure–Kunkel, Nathan O. Siemers, Jeffrey R. Jackson, Vafa Shahabi - Cancer Immunology Immunotherapy 2011 被引用: 777

  8. A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma

    著者: Omid Hamid, Henrik Schmidt, Aviram Nissan, Laura Ridolfi, Steinar Aamdal, Johan Hansson, Michele Guida, David M. Hyams, Henry Gómez, Lars Bastholt, Scott D. Chasalow, David M. Berman - Journal of Translational Medicine 2011 被引用: 531

  9. Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-up

    著者: Laurence Klotz, Gregory R. Pond, Andrew Loblaw, Linda Sugar, Madeline Moussa, David M. Berman, Theodorus van der Kwast, Danny Vesprini, Laurent Milot, Marlene Kebabdjian, Neil Fleshner, Sangheet Ghai, Joseph L. Chin, Masoom A. Haider - European Urology 2019 被引用: 153

  10. Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma

    著者: Jedd D. Wolchok, F. Stephen Hodi, Jeffrey S. Weber, James P. Allison, Walter J. Urba, Caroline Robert, Steven O’Day, Axel Hoos, Rachel Humphrey, David M. Berman, Nils Lönberg, Alan J. Korman - Annals of the New York Academy of Sciences 2013 被引用: 307

  11. Gene expression profiling of whole blood in ipilimumab-treated patients for identification of potential biomarkers of immune-related gastrointestinal adverse events

    著者: Vafa Shahabi, David M. Berman, Scott D. Chasalow, Lisu Wang, Zenta Tsuchihashi, Beihong Hu, Lisa Panting, Maria Jure–Kunkel, Rui‐Ru Ji - Journal of Translational Medicine 2013 被引用: 173

  12. Hedgehog signalling in prostate regeneration, neoplasia and metastasis

    著者: Sunil Karhadkar, G. Steven Bova, Nadia M. Abdallah, Surajit Dhara, Dale R. Gardner, Anirban Maitra, John T. Isaacs, David M. Berman, Philip A. Beachy - Nature 2004 被引用: 947

  13. A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable Stage III or IV Melanoma

    著者: Jeffrey S. Weber, John A. Thompson, Omid Hamid, David R. Minor, Asim Amin, Ilan G. Ron, Ruggero Ridolfi, Hazem Assi, Anthony Maraveyas, David M. Berman, Jonathan Siegel, Steven O’Day - Clinical Cancer Research 2009 被引用: 567

  14. Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer

    著者: Madhuri Koti, Amanda Shuo Xu, Kevin Ren, Kash Visram, Runhan Ren, David M. Berman, D. Robert Siemens - Bladder Cancer 2017 被引用: 75

  15. Graphs with homeomorphically irreducible spanning trees

    著者: Michael O. Albertson, David M. Berman, Joan P. Hutchinson, Carsten Thomassen - Journal of Graph Theory, J. Graph Theory 1990 被引用: 40

  16. The safety and feasibility of probiotics in children and adolescents undergoing hematopoietic cell transplantation

    著者: Elena J. Ladas, Monica Bhatia, Lu Chen, Eric Sandler, Aleksandra Petrović, David M. Berman, Frances Hamblin, Michael Gates, R. Hawks, Lillian Sung, Michael L. Nieder - Bone Marrow Transplantation 2015 被引用: 132

  17. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours

    著者: David M. Berman, Sunil Karhadkar, Anirban Maitra, Rocío Montes de, Meg R. Gerstenblith, Kimberly J. Briggs, Antony R. Parker, Yutaka Shimada, James R. Eshleman, D. Neil Watkins, Philip A. Beachy - Nature 2003 被引用: 1,257

  18. Tissue repair and stem cell renewal in carcinogenesis

    著者: Philip A. Beachy, Sunil Karhadkar, David M. Berman - Nature 2004 被引用: 1,211

  19. GAIP and RGS4 Are GTPase-Activating Proteins for the Gi Subfamily of G Protein α Subunits

    著者: David M. Berman, Thomas M. Wilkie, Alfred G. Gilman - Cell 1996 被引用: 742

  20. Development of Ipilimumab: Contribution to a New Paradigm for Cancer Immunotherapy

    著者: Axel Hoos, Ramy Ibrahim, Alan J. Korman, Kald Abdallah, David M. Berman, Vafa Shahabi, Kevin M. Chin, Renzo Canetta, Rachel Humphrey - Seminars in Oncology 2010 被引用: 239

  21. International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma

    著者: Theodorus van der Kwast, Fredrik Liedberg, Peter C. Black, Ashish M. Kamat, Bas W.G. van Rhijn, Ferrán Algaba, David M. Berman, Arndt Hartmann, Antonio López-Beltrán, Hemamali Samaratunga, Murali Varma, Liang Cheng - European Urology Focus 2021 被引用: 45

  22. Structure of RGS4 Bound to AlF4−-Activated Giα1: Stabilization of the Transition State for GTP Hydrolysis

    著者: J.J.G. Tesmer, David M. Berman, Alfred G. Gilman, Stephen R. Sprang - Cell 1997 被引用: 790

  23. Molecular profiling in muscle‐invasive bladder cancer: more than the sum of its parts

    著者: Gottfrid Sjödahl, Chelsea Jackson, John M.S. Bartlett, D. Robert Siemens, David M. Berman - The Journal of Pathology 2019 被引用: 89

  24. PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells

    著者: Thiago Vidotto, Fabiano Pinto Saggioro, Tamara Jamaspishvili, Deise L. Chesca, Clarissa Gondim Picanço de Albuquerque, Rodolfo Borges dos Reis, Charles H. Graham, David M. Berman, D. Robert Siemens, Jeremy A. Squire, Madhuri Koti - The Prostate 2019 被引用: 86